Portfolio Design Labs’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Buy
11,543
+345
+3% +$30.2K 0.17% 117
2026
Q1
$954K Sell
11,198
-1,315
-11% -$117K 0.17% 135
2025
Q4
$989K Buy
12,513
+436
+4% +$34.2K 0.16% 139
2025
Q3
$965K Buy
+12,077
New +$1.03M 0.17% 143
2025
Q1
Sell
-2,512
Closed -$228K 201
2024
Q4
$228K Buy
+2,512
New +$240K 0.05% 178
2024
Q1
Sell
-5,936
Closed -$473K 115
2023
Q4
$473K Buy
+5,936
New +$446K 0.18% 87

Other funds holding CL

Portfolio Design Labs's CL Position: Q2 2026 in Review

Portfolio Design Labs increased its Colgate-Palmolive (CL) stake by 3.1% in Q2 2026, buying an estimated $30.2K and bringing the position to 11,543 shares worth $1.06M. The position accounts for 0.17% of the portfolio, ranked #117.

Portfolio Design Labs first reported a position in CL in Q4 2023 and has held it in 6 quarters since. 2,025 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Portfolio Design Labs held 11,543 shares of Colgate-Palmolive worth $1.06M as of Q2 2026.
  • Portfolio Design Labs bought 345 Colgate-Palmolive shares in Q2 2026, an estimated $30.2K.
  • Colgate-Palmolive made up 0.17% of Portfolio Design Labs's portfolio in Q2 2026, its #117 holding.
  • Portfolio Design Labs first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 6 quarters since.
  • 2,025 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Portfolio Design Labs's 13F filing for Q2 2026, filed 11 Aug 2026.